Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides. NICE technology appraisal guidance 805
National Institute for Health and Care Excellence (NICE)
Record ID 32018011847
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/ta805
Year Published:
2022
URL for published report:
https://www.nice.org.uk/guidance/ta805
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Cardiovascular Diseases
- Cholesterol, LDL
- Triglycerides
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Eicosapentaenoic Acid
- Hypertriglyceridemia
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.